False Claims Act & Whistleblower Defense
Clients praise Latham for its "outstanding credibility with the DOJ," adding: "I wouldn't pick anyone else to handle a significant matter."
Chambers USA 2020
Latham represents individuals and companies across a wide range of industries in complex investigations and high-stakes fraud matters alleging violations of the US False Claims Act (FCA), Anti-Kickback Statute (AKS), and other claims brought by the US federal government and/or qui tam whistleblowers. Drawing on the unique government experience of many lawyers in the practice, we have a long record of successfully resolving FCA matters for clients.
We counsel clients at every stage of an FCA civil proceeding, from the critical investigation period — when the qui tam case is under seal — to trial and appeal. We have developed encyclopedic knowledge of healthcare and government contracts regulatory law, which we combine with our experience handling the unique aspects of FCA matters. We craft effective legal strategies to mitigate potential FCA liability. Our FCA practitioners provide invaluable insight into investigating, litigating, and settling FCA cases, and the key strategic considerations at each of these stages.
Market Leaders in Healthcare FCA Defense
Latham's team of healthcare enforcement lawyers provides comprehensive counsel in FCA actions by combining deep substantive knowledge of healthcare laws and regulations with expertise resolving FCA issues. Drawing on an extensive understanding of the sector's varied business models and operations, Latham defends the country's largest hospital systems, healthcare companies, and pharmaceutical and medical device manufacturers in the highest stakes healthcare fraud investigations.
Dedicated Government Contracts Team for FCA Dispute Resolution
Latham's Government Contracts Practice draws on decades of experience handling virtually all government contract-related issues. Latham's team of FCA lawyers leverage their insight in government contracts laws and regulations to craft strategies to resolve FCA procurement matters favorably. We represent traditional defense contractors and companies in a full range of industries, including in the financial services, IT, and healthcare industries.
Our Team Includes:
Two former heads of the Criminal Division of the Department of Justice and chair of the National Procurement Fraud Task Force
The former deputy head of the Civil Division of the Department of Justice and General Counsel of Health and Human Services
Many Assistant US Attorneys
Latham represents clients in complex investigations and high-stakes fraud matters alleging violations of the FCA, AKS, and other claims brought by the US federal government and/or qui tam whistleblowers.
Daniel Meron
daniel.meron@lw.com +1.202.637.2218
October 31, 2022Recognition
Crisis Management and Government Oversight—Finalist
Firm honored for regularly delivering results that dramatically reduce our clients' financial exposure, prevent or navigate through potentially debilitating litigation, and manage possibly brand-destroying public discourse.
December 16, 2020Recognition
Six Washington, D.C. Partners Recognized as Top Lawyers by Washingtonian
Lawyers recognized for being the area's best legal talent.
White Collar MVP: Alice Fisher
Washington, D.C. partner recognized for securing a settlement with the US Department of Justice on behalf of a pharmaceutical client related to the sale and marketing of a pain management drug.
April 4, 2022 Press Release
Latham Adds Another Leading White Collar Defense & Investigations Lawyer
Experienced trial lawyer Christopher D. Frey advises major global companies on a variety of white collar and regulatory defense matters.
February 11, 2022 Our Work
Litigators of the Week: The Latham & Watkins Duo Who Paved the Path for Mallinckrodt to Exit Bankruptcy
Despite objections from the U.S. Trustee, the SEC, the state of Rhode Island and others, Latham's Chris Harris and Betsy Marks were able to get judicial sign-off on the pharma company's reorganization plan, including a US$1.7 billion settlement of opioid-related litigation.
July 8, 2019 Our Work
Court Rips 'Legal Artifice' in Kasowitz Firm's Megabillions Whistleblower Case
Latham secured dismissal in district court and affirmance on appeal on behalf of the Dow Chemical Company in a case in which plaintiffs were seeking billions of dollars in False Claims Act damages.
White Collar Defense & InvestigationsHealthcare & Life SciencesLitigation & Trial
False Claims Act Resource Center
Robust collection of materials essential to formulating an effective strategy for responding to an FCA matter.
We've Got Washington Covered
Insights to help navigate the crossroads of national policy, regulation, and legislation that is Washington.